MANGOCEUTICALS, INC. Files 8-K with Bylaw Amendments and Exhibits

Ticker: MGRX · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1938046

Mangoceuticals, INC. 8-K Filing Summary
FieldDetail
CompanyMangoceuticals, INC. (MGRX)
Form Type8-K
Filed DateJul 10, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, filing, exhibits

TL;DR

MANGOCEUTICALS, INC. filed an 8-K on 7/3/25 for bylaw changes and financials.

AI Summary

On July 3, 2025, MANGOCEUTICALS, INC. filed an 8-K report detailing amendments to its articles of incorporation or bylaws and including financial statements and exhibits. The company, incorporated in Texas with its principal executive offices in Dallas, operates in the health and allied services sector.

Why It Matters

This filing provides updated corporate governance information and financial disclosures for MANGOCEUTICALS, INC., which is important for investors to understand the company's structure and financial health.

Risk Assessment

Risk Level: low — This is a routine filing of corporate information and exhibits, not indicating any immediate financial distress or significant operational change.

Key Numbers

Key Players & Entities

FAQ

What specific amendments were made to the articles of incorporation or bylaws?

The filing indicates amendments were made, but the specific details of these amendments are not provided in the summary text, likely contained within the attached exhibits.

What is the SIC code for MANGOCEUTICALS, INC.?

The Standard Industrial Classification (SIC) code for MANGOCEUTICALS, INC. is 8090, which falls under SERVICES-MISC HEALTH & ALLIED SERVICES, NEC.

When is MANGOCEUTICALS, INC.'s fiscal year end?

MANGOCEUTICALS, INC.'s fiscal year ends on December 31st.

What is the primary business address of MANGOCEUTICALS, INC.?

The primary business address is 15110 DALLAS PKWY, SUITE 600, DALLAS, TX 75248.

What is the phone number listed for MANGOCEUTICALS, INC.?

The registrant's telephone number, including area code, is (214) 242-9619.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding MANGOCEUTICALS, INC. (MGRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing